Singapore, Feb. 11 -- Singapore will begin providing subsidies and allow individuals to use their personal medical savings for shingles vaccination, the Ministry of Health announced on Monday.
Starting from September 2025, eligible Singaporeans and permanent residents will be able to receive means-tested subsidies of up to 75 percent for Shingrix, the only vaccine currently approved by the Health Sciences Authority for shingles prevention, the ministry said in a statement.
As part of this initiative, seniors from the Pioneer Generation and the Merdeka Generation, two programs aimed at recognizing the contributions of these older generations to Singapore's early development, will receive additional subsidies for outpatient vaccinations....